Search Results - "Peter, Wipfler"

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry by Bsteh, Gabriel, Assar, Hamid, Hegen, Harald, Heschl, Bettina, Leutmezer, Fritz, Di Pauli, Franziska, Gradl, Christiane, Traxler, Gerhard, Zulehner, Gudrun, Rommer, Paulus, Wipfler, Peter, Guger, Michael, Enzinger, Christian, Berger, Thomas

“…Background The COVID-19 pandemic challenges neurologists in counselling patients with multiple sclerosis (pwMS) regarding their risk by SARS-CoV-2 and in…”
Get full text

Tick-Borne Encephalitis Virus RNA Found in Frozen Goat’s Milk in a Family Outbreak by Mylonaki, Eirini, Seiberl, Michael, Jones, Neil, Bernhard, Heike, Otto, Ferdinand, Pilz, Georg, Trinka, Eugen, Wipfler, Peter

“…Tick-borne encephalitis (TBE) is one of the commonest arthropod-borne viral diseases in Middle-East Europe and North Asia. The main reservoir of the virus is…”
Get full text

Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders-A Pilot Study by Foettinger, Fabian, Pilz, Georg, Wipfler, Peter, Harrer, Andrea, Kern, Jan Marco, Trinka, Eugen, Moser, Tobias

“…Therapeutic plasma exchange (TPE) is used for drug-resistant neuroimmunological disorders, but its mechanism of action remains poorly understood. We therefore…”
Get full text

Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting by Seiberl, Michael, Feige, Julia, Hilpold, Patrick, Hitzl, Wolfgang, Machegger, Lukas, Buchmann, Arabella, Khalil, Michael, Trinka, Eugen, Harrer, Andrea, Wipfler, Peter, Moser, Tobias

“…Serum neurofilament light chain (sNfL) is an intensely investigated biomarker in multiple sclerosis (MS). The aim of this study was to explore the impact of…”
Get full text

Long‐term outcome after COVID‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study by Bsteh, Gabriel, Assar, Hamid, Gradl, Christiane, Heschl, Bettina, Hiller, Maria‐Sophie, Krajnc, Nik, Di Pauli, Franziska, Hegen, Harald, Traxler, Gerhard, Leutmezer, Fritz, Wipfler, Peter, Zulehner, Gudrun, Guger, Michael, Enzinger, Christian, Berger, Thomas, Doris, Aigner, Hamid, Assar, Thomas, Berger, Klaus, Böck, Christian, Bsteh, Gabriel, Bsteh, Pauli, Di, Christian, Enzinger, Christiane, Gradl, Elisabeth, Gruber, Michael, Guger, Harald, Hegen, Bettina, Heschl, Marie‐Sophie, Hiller, Barbara, Kornek, Heidi, Lemmerer, Fritz, Leutmezer, Camillo, Lex, Markus, Mayr, Gabriele, Morgenstern, Dirk, Oel, Paulus, Rommer, Peter, Schnabl, Gabriela, Schneider‐Koch, Gabriele, Schrotter, Gerhard, Traxler, Peter, Wipfler, Gudrun, Zulehner, Tobias, Zrzavy

“…Background and purpose Long‐term outcome after COVID‐19 in patients with multiple sclerosis (pwMS) has scarcely been studied, and controlled data are lacking…”
Get full text

The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF by Harrer, Christine, Otto, Ferdinand, Pilz, Georg, Haschke-Becher, Elisabeth, Trinka, Eugen, Hitzl, Wolfgang, Wipfler, Peter, Harrer, Andrea

“…C-X-C chemokine ligand 13 (CXCL13) is frequently elevated in cerebrospinal fluid (CSF) in a variety of inflammatory central nervous system (CNS) diseases, has…”
Get full text

The CXCL13/CXCR5 Immune Axis in Health and Disease—Implications for Intrathecal B Cell Activities in Neuroinflammation by Harrer, Christine, Otto, Ferdinand, Radlberger, Richard Friedrich, Moser, Tobias, Pilz, Georg, Wipfler, Peter, Harrer, Andrea

“…The chemokine C-X-C- ligand 13 (CXCL13) is a major B cell chemoattractant to B cell follicles in secondary lymphoid organs (SLO) that proposedly recruits B…”
Get full text

Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study by Pilz, Georg, Wipfler, Peter, Otto, Ferdinand, Hitzl, Wolfgang, Afazel, Shahrzad, Haschke-Becher, Elisabeth, Trinka, Eugen, Harrer, Andrea

“…The chemokine CXCL13 is an intensively investigated biomarker in Lyme neuroborreliosis (LNB). Its role in other neuroinfections is increasingly recognized but…”
Get full text

Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities by Otto, Ferdinand, Harrer, Christine, Pilz, Georg, Wipfler, Peter, Harrer, Andrea

“…Cerebrospinal fluid (CSF) has recently experienced a revival in diagnostics and research. However, little progress has been made regarding CSF cell analysis…”
Get full text

Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction by Pilz, Georg, Sakic, Irma, Wipfler, Peter, Kraus, Jörg, Haschke-Becher, Elisabeth, Hitzl, Wolfgang, Trinka, Eugen, Harrer, Andrea

“…Elevation of the chemokine CXCL13 in CSF frequently occurs during active and acute CNS inflammatory processes and presumably is associated with B cell-related…”
Get full text

Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study by Moser, Tobias, O’Sullivan, Ciara, Otto, Ferdinand, Hitzl, Wolfgang, Pilz, Georg, Schwenker, Kerstin, Mrazek, Cornelia, Haschke-Becher, Elisabeth, Trinka, Eugen, Wipfler, Peter, Harrer, Andrea

“…Background: Anti-CD20 therapies induce pronounced B-cell depletion and blunt humoral responses to vaccines. Recovery kinetics of anti-CD20 therapy-mediated…”
Get full text

Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients by Moser, Tobias, Seiberl, Michael, Feige, Julia, Bieler, Lara, Radlberger, Richard F., O’Sullivan, Ciara, Pilz, Georg, Harrer, Andrea, Schwenker, Kerstin, Haschke-Becher, Elisabeth, Machegger, Lukas, Grimm, Jochen, Redlberger-Fritz, Monika, Buchmann, Arabella, Khalil, Michael, Kvas, Erich, Trinka, Eugen, Wipfler, Peter

“…BackgroundEfficacy of vaccines and disease activity linked to immunization are major concerns among people with multiple sclerosis (pwMS). ObjectiveTo assess…”
Get full text

Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study by Karamyan, Anush, Dünser, Martin W, Wiebe, Douglas J, Pilz, Georg, Wipfler, Peter, Chroust, Vaclav, Novak, Helmut F, Hauer, Larissa, Trinka, Eugen, Sellner, Johann

“…Over the course of multiple sclerosis (MS) several conditions may arise that require critical care. We aimed to study the reasons for admission and outcome in…”
Get full text

Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery by Feige, Julia, Berek, Klaus, Seiberl, Michael, Hilpold, Patrick, Hitzl, Wolfgang, Di Pauli, Franziska, Hegen, Harald, Deisenhammer, Florian, Trinka, Eugen, Harrer, Andrea, Wipfler, Peter, Moser, Tobias

“…Anti-CD20 therapies decrease the humoral response to SARS-CoV-2 immunization. We aimed to determine the extent of the humoral response to SARS-CoV-2 antigens…”
Get full text

Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy by Moser, Tobias, O’Sullivan, Ciara, Puttinger, Christian, Feige, Julia, Pilz, Georg, Haschke-Becher, Elisabeth, Cadamuro, Janne, Oberkofler, Hannes, Hitzl, Wolfgang, Harrer, Andrea, Kraus, Jörg, Trinka, Eugen, Wipfler, Peter

“…Cladribine (CLAD) is a lymphodepleting agent approved for active relapsing multiple sclerosis (MS). The impact of CLAD on the adaptive humoral immune system…”
Get full text

Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod by Harrer, Andrea, Wipfler, Peter, Pilz, Georg, Oppermann, Katrin, Haschke-Becher, Elisabeth, Afazel, Shahrzad, Kraus, Jörg, Trinka, Eugen, Sellner, Johann

“…Fingolimod, an oral sphingosine 1-phosphate (S1P) receptor modulator, is approved for the treatment of relapsing forms of multiple sclerosis (MS). The…”
Get full text

Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis by Harrer, Andrea, Pilz, Georg, Einhaeupl, Max, Oppermann, Katrin, Hitzl, Wolfgang, Wipfler, Peter, Sellner, Johann, Golaszewski, Stefan, Afazel, Shahrzad, Haschke-Becher, Elisabeth, Trinka, Eugen, Kraus, Joerg

“…Natalizumab is an effective monoclonal antibody therapy for the treatment of relapsing-remitting multiple sclerosis (RRMS) and interferes with immune cell…”
Get full text

Serial flow cytometric analyses of blood and cerebrospinal fluid in natalizumab-associated progressive multifocal leukencephalopathy with an excellent outcome by Pilz, Georg, Harrer, Andrea, Wipfler, Peter, Oppermann, Katrin, Sellner, Johann, Rispens, Theo, van der Kleij, Desiree, Afazel, Shahrzad, Haschke-Becher, Elisabeth, Trinka, Eugen, Kraus, Joerg

Get full text

Tumefactive MS lesions under fingolimod: A case report and literature review by Pilz, Georg, Harrer, Andrea, Wipfler, Peter, Oppermann, Katrin, Sellner, Johann, Fazekas, Franz, Trinka, Eugen, Kraus, Joerg

“…OBJECTIVE:To report about a possible association between fingolimod treatment and tumefactive demyelinating lesions (TDL) as seen in a patient developing…”
Get full text

Beyond T cell toxicity-Intrathecal chemokine C-X-C motif ligand indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review by Otto, Ferdinand, Seiberl, Michael, Lara, Bieler, Moser, Tobias, Kleindienst, Waltraud, Walter, Wallner-Essl, Peter, Koelblinger, Wipfler, Peter, Harrer, Andrea

“…This study was undertaken to raise awareness of a role of B cells in immune checkpoint inhibitor (ICI)-associated neurological immune-related adverse events…”
Get full text